# Invesco CurrencyShares Euro Trust: overview FXE · NYSE · CIK 1328598 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fxe.md) · [Financials](/companies/fxe/financials.md) · [Filings](/companies/fxe/filings.md) · [Insiders](/companies/fxe/insiders.md) Latest reported revenue: [$1.2m](/filings/0001193125-26-338695.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338695). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,118](/filings/0001193125-25-270311.md) | [933 d](/filings/0001193125-26-083564.md) | [746](/filings/0001193125-26-209717.md) | [1,562](/filings/0001193125-26-338695.md) | [1,524](/filings/0001193125-25-270311.md) | [1,253 d](/filings/0001193125-26-083564.md) | [1,260](/filings/0001193125-26-209717.md) | [1,217](/filings/0001193125-26-338695.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [84.1%](/filings/0001193125-25-270311.md) | [81.4% d](/filings/0001193125-26-083564.md) | [77.0%](/filings/0001193125-26-209717.md) | [69.2%](/filings/0001193125-26-338695.md) | [64.0%](/filings/0001193125-25-270311.md) | [64.2% d](/filings/0001193125-26-083564.md) | [65.0%](/filings/0001193125-26-209717.md) | [65.1%](/filings/0001193125-26-338695.md) | | Diluted EPS | $ per share | [0.54](/filings/0001193125-25-270311.md) | not reported | [0.32](/filings/0001193125-26-209717.md) | [0.23](/filings/0001193125-26-338695.md) | [0.19](/filings/0001193125-25-270311.md) | not reported | [0.20](/filings/0001193125-26-209717.md) | [0.20](/filings/0001193125-26-338695.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | [331](/filings/0000950170-24-019061.md) | [5,304](/filings/0000950170-25-027270.md) | [4,736](/filings/0001193125-26-083564.md) | [5,085](/filings/0001193125-26-083564.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | [(539.8%)](/filings/0000950170-24-019061.md) | [80.5%](/filings/0000950170-25-027270.md) | [84.2%](/filings/0001193125-26-083564.md) | [67.6%](/filings/0001193125-26-083564.md) | | Diluted EPS | $ per share | [(1.13)](/filings/0001564590-23-002366.md) | [(0.62)](/filings/0000950170-24-019061.md) | [1.65](/filings/0000950170-25-027270.md) | [2.15](/filings/0001193125-26-083564.md) | [0.88](/filings/0001193125-26-083564.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fxe/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $36.6m | 346,735 | | Reduced −679,026 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $24.5m | 232,623 | | Added +196,900 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $15.8m | 150,201 | | Reduced −156,272 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $10.4m | 98,200 | Call | Reduced −10,400 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $8.8m | 83,800 | Put | Reduced −34,900 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $7.9m | 75,009 | | Reduced −25,000 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $6.6m | 62,500 | Put | Added +6,300 | | [Advisory Services Network, LLC](/funds/1573876.md) | 2026-06-30 | $6.1m | 57,961 | | Reduced −114 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $4.0m | 38,351 | | Reduced −20,615 | | [LEUTHOLD GROUP, LLC](/funds/1170152.md) | 2026-06-30 | $3.7m | 34,948 | | Reduced −5,831 | ## Recent filings [All 223 filings](/companies/fxe/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-21 | 20:05 ET | [8-K](/filings/0001193125-26-427819.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-427819 | | 2026-08-07 | 23:21 ET | [10-Q](/filings/0001193125-26-338695.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338695 | | 2026-08-03 | 20:05 ET | [8-K](/filings/0001193125-26-330545.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-330545 | | 2026-06-08 | 21:34 ET | [8-K](/filings/0001193125-26-260014.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-260014 | | 2026-05-07 | 23:46 ET | [10-Q](/filings/0001193125-26-209717.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209717 | | 2026-03-02 | 23:51 ET | [10-K](/filings/0001193125-26-083564.md) | Annual report, period 2025-12-31 | 0001193125-26-083564 | | 2025-11-07 | 23:58 ET | [10-Q](/filings/0001193125-25-270311.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270311 | | 2025-08-07 | 20:42 ET | [10-Q](/filings/0000950170-25-105145.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105145 | | 2025-05-08 | 21:14 ET | [10-Q](/filings/0000950170-25-067217.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067217 | | 2025-02-26 | 02:42 ET | [10-K](/filings/0000950170-25-027270.md) | Annual report, period 2024-12-31 | 0000950170-25-027270 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-083564.md), filed Mar 2, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/65766b34-24c0-4478-874b-f45d7e1f3279) ## About the filer - CIK: 1328598 - Tickers: FXE - Exchange: NYSE - SIC code: 6221 Commodity Contracts Brokers & Dealers - State of incorporation: NY - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.